![Courtney Dugan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Courtney Dugan
Contatto Relazioni con gli Investitori presso
YMAS THER
Profilo
Ms. Courtney Dugan is a Vice President-Investor Relations at Y-mAbs Therapeutics, Inc. and an Investor Relations Contact at Immuneering Corp.
Ms. Dugan was previously employed as a Vice President-Investor Relations by Pyxis Oncology, Inc. and a Vice President-Healthcare Investor Relations by ICR LLC.
Posizioni attive di Courtney Dugan
| Società | Posizione | Inizio |
|---|---|---|
| YMAS THER | Contatto Relazioni con gli Investitori | 01/05/2023 |
| IMMUNEERING CORPORATION | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Courtney Dugan
| Società | Posizione | Fine |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Contatto Relazioni con gli Investitori | 01/10/2022 |
ICR LLC
 ICR LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications and advisory ?rm | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
48
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
ICR LLC
ICR LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications and advisory ?rm | Commercial Services |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
